Skip to main content
. Author manuscript; available in PMC: 2016 Jan 28.
Published in final edited form as: AIDS. 2015 Jan 28;29(3):323–330. doi: 10.1097/QAD.0000000000000553

Figure 2. Virally suppressive ART exerts a protective effect against measures of synaptodendritic neurodegeneration.

Figure 2

(a) Comparison of MAP2 percentage across ART groups. The S-ART group shows higher MAP2 percentages than the NS-ART group (p = 0.044, one-way ANOVA followed by Tukey's post hoc test). (b) Comparison of SYP percentage across ART groups. The S-ART group shows higher SYP percentage when compared to ART Naïve (p = 0.007, one-way ANOVA followed by Tukey's post hoc test). (c) Comparison of ND score across ART groups. The S-ART group shows lower ND score, representing less neurodegeneration, when compared to ART naïve (p = 0.01, one-way ANOVA followed by Tukey's post hoc test). * p < 0.05; ** p < 0.01.